Processed Meat Raises Stomach and Esophageal Cancer Risk, Large European Study Finds

Cancer researchers have long suspected that what people eat shapes their risk of cancers deep in the digestive tract, but pinning down specific culprits has proven difficult. A new analysis from the European Prospective Investigation Into Cancer and Nutrition, known as EPIC, now adds some of the clearest prospective evidence yet: processed meat consumption was significantly associated with both gastric and esophageal adenocarcinoma risk across a cohort of 450,112 adults from 10 European countries, followed for an average of 14.1 years.

Processed Meat and Gastric Cancer Risk in 450,000 Europeans

The headline numbers are modest but consistent. Every additional 30 grams of processed meat per day, roughly two strips of bacon or a couple of slices of ham, was associated with a 9% higher risk of gastric cancer (95% CI: 2 to 17%) and a 13% higher risk of esophageal adenocarcinoma (95% CI: 0 to 27%). Over the study period, researchers identified 876 gastric cancer cases and 215 esophageal adenocarcinoma cases. The association with gastric cancer held across both intestinal-type tumors, where processed meat was linked to an 11% increase per 30g per day, and diffuse-type tumors. Notably, red meat showed no significant association with either cancer, and neither did total meat intake taken as a single category. The signal was specific to the processed variety.

The IARC classifies processed meat as a Group 1 carcinogen, meaning there is sufficient evidence that it causes cancer in humans, with stomach cancer listed among the linked sites. The EPIC findings are consistent with that classification, though the study adds important granularity by subtype and anatomical location that earlier evidence lacked.

Why Gastric and Esophageal Adenocarcinoma Are a Growing Problem

Gastric cancer is the fifth most commonly diagnosed cancer worldwide, and esophageal cancer ranks eleventh. Global estimates place new cases of gastric cancer at over 1 million annually, with esophageal cancers adding roughly 572,000 more. What makes the picture more urgent in Western countries is the trajectory of esophageal adenocarcinoma specifically: incidence is rising, and projections suggest that 1 in 100 men in the Netherlands and the United Kingdom will be diagnosed by 2030.

Both cancer types are increasingly understood to share biological roots. Researchers now view gastric and esophageal adenocarcinomas as related conditions that can arise from common gastric stem or progenitor cells, which partly explains why a single dietary exposure can influence risk across both sites. Established risk factors for gastric cancer include Helicobacter pylori infection, tobacco, alcohol, high-salt diets, and, for cardia gastric cancer, excess body weight. For esophageal adenocarcinoma, gastroesophageal reflux disease, body fatness, and tobacco are the clearest culprits. Diet, and processed meat in particular, now looks like an underappreciated variable on top of those established risks.

How the EPIC Cohort Captured Dietary Exposure Before Disease

The methodological strength of this analysis rests on its prospective design. Prospective cohort studies collect dietary and lifestyle data before disease onset, which eliminates the recall bias that plagues case-control studies where participants are asked to remember what they ate years before a diagnosis. EPIC recruited participants across 10 European countries, used country-specific validated food frequency questionnaires at baseline to estimate red, processed, and white meat intake in grams per day, and then tracked participants forward in time until 2015.

The analytical team used multivariable Cox proportional hazards models, adjusting for age, sex, total energy intake, education, body mass index, alcohol consumption, and smoking. They also ran sensitivity analyses that excluded cases diagnosed within the first two years of follow-up to reduce the chance that undetected pre-existing cancer was distorting dietary reports at baseline. Gastric cancers were classified both by anatomical location (cardia versus non-cardia) and by Lauren histological type (intestinal versus diffuse), giving the analysis more resolution than most prior work.

Sex-stratified results revealed an interesting divergence. Among men, only processed meat was associated with gastric cancer risk, at a 10% increase per 30g per day. Among women, both processed meat (9% per 30g per day) and white meat (11% per 20g per day) showed positive associations with gastric cancer, with white meat specifically linked to non-cardia tumors. The white meat finding is unexpected and deserves scrutiny: white meat generally carries lower heme iron than red meat and higher polyunsaturated fat content, factors usually considered protective. The authors suggest that high-temperature cooking methods, protein-driven gut microbiota changes, or other mechanisms could be involved, but this association requires replication.

Biological Mechanisms That Could Explain the Meat-Cancer Link

Several plausible biological pathways connect processed meat to upper gastrointestinal cancers. The most discussed involves heme iron, which promotes the formation of N-nitroso compounds (NOCs) in the gut. NOCs are potent carcinogens that can alkylate DNA, and processed meats are also a direct source of nitrates and nitrites used as preservatives, which can be converted to NOCs in the stomach. High-temperature cooking of any meat, whether grilling, frying, or smoking, also generates heterocyclic amines and polycyclic aromatic hydrocarbons, both of which damage DNA. Research into the mechanisms linking meat consumption to cancer has confirmed that these pathways are biologically active in humans, even if their relative contributions are still being weighed.

Processed meats also tend to be high in sodium. Chronic high-salt exposure irritates the gastric mucosa, promotes inflammation, and is thought to amplify the carcinogenic effects of H. pylori infection, which the EPIC analysis was not able to directly account for. That gap is one of the study's acknowledged limitations.

Open Questions and What the Study Cannot Settle

This is emerging evidence, not a closed case. Food frequency questionnaires introduce measurement imprecision, and the assumption that baseline dietary habits remained stable across 14 years of follow-up is acknowledged as a potential source of bias, though sensitivity analyses were performed to probe this. Observational diet-cancer studies are also susceptible to weakening associations over long follow-up periods as dietary patterns shift and participants' reporting accuracy fades with time.

The esophageal adenocarcinoma findings are intriguing but tentative: only 215 cases were identified overall, and just 46 occurred in women, which is almost certainly why no significant associations appeared in that subgroup. Larger studies with more EAC cases, particularly in women, will be needed before the 13% risk increase for processed meat can be treated as robust.

The EPIC data nonetheless suggest that processed meat deserves a place in conversations about upper gastrointestinal cancer prevention alongside the more established risk factors. For now, the findings support existing public health guidance to limit processed meat, while researchers work to clarify the magnitude of risk and the mechanisms driving it.

Evidence rating

EMERGING — 82/100

Caveats:

• This is an observational cohort study — it shows association, not causation. Diet was measured once at baseline using food frequency questionnaires, which are prone to recall and measurement error.
• The EAC findings are based on only 215 cases total, and just 46 in women, so those subgroup estimates are statistically fragile.
• H. pylori infection status — a major gastric cancer risk factor — was not accounted for, which could confound the results.
• Funding was not disclosed in the available record; independent replication of these findings is needed before drawing firm dietary conclusions.

Large prospective cohort study (n=450,112; 14.1 years follow-up) from 10 European countries. Findings reflect associations measured at a single dietary baseline, not experimentally established causation, and the study did not account for H. pylori infection status. The white meat association with non-cardia gastric cancer and the esophageal adenocarcinoma findings are based on relatively small case counts and have not yet been independently replicated at this scale.

References

1. Catalina Bonet, Lucía Rizzolo‐Brime, Sara Montañés, et al. (2026). Meat Intake and Risk of Gastric and Esophageal Adenocarcinoma in the European Prospective Investigation Into Cancer and Nutrition ( EPIC ) Study. International Journal of Cancer. https://doi.org/10.1002/ijc.70486
2. Red Meat and Processed Meat Consumption – Cancer Trends Progress Report. progressreport.cancer.gov. https://progressreport.cancer.gov/prevention/red_meat
3. Global burden of oesophageal and gastric cancer by histology and subsite in 2018 – PubMed. NIH. https://pubmed.ncbi.nlm.nih.gov/32606208/
4. Power of Cohorts: Public Health Advances from Prospective Cohort Studies – DCEG. dceg.cancer.gov. https://dceg.cancer.gov/about/highlights/power-of-cohorts
5. Robert J. Turesky (2018). Mechanistic Evidence for Red Meat and Processed Meat Intake and Cancer Risk: A Follow-up on the International Agency for Research on Cancer Evaluation of 2015. CHIMIA. https://doi.org/10.2533/chimia.2018.718
6. William B. Grant (2023). Long Follow-Up Times Weaken Observational Diet–Cancer Study Outcomes: Evidence from Studies of Meat and Cancer Risk. Nutrients. https://doi.org/10.3390/nu16010026